Skip to Content

Grant Support

Hyundai Hope on Wheels, "A Novel Phospholipid Ether Analog to Combine Targeted Molecular Radiotherapy and Immunotherapy in Pediatric Solid Tumors (2015-2018). Otto, Principal Investigator

NIH-NCI (R21 CA198392), “A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors” (2015-2017).  Otto, PI.

Midwest Athletes Against Childhood Cancer, “Effect of zoledronate on engraftment and t-cell development after TCR alpha-ß/CD19-depleted hematopoietic stem cell transplantation” (2015-2017).  Otto, PI

Midwest Athletes Against Childhood Cancer, “Clr1404 - A tumor-selective alkyl phospholipid analog for the treatment of pediatric solid malignancies” (2015-2017).  Otto, PI

AACR-St. Baldrick’s-SU2C Foundations “Immunogenomics to create new therapies for high-risk childhood cancers” (2013-2017).  Otto, Young Investigator

Midwest Athletes Against Childhood Cancer, “Alpha/beta t-cell depleted haploidentical transplantation with post-transplant zoledronic acid to treat recurrent or refractory pediatric malignancies” (2013-2015).  Otto, Co-Investigator

Completed Grants

Midwest Athletes Against Childhood Cancer, “Development of multifunctional superparamagnetic anti-GD2 nanoparticles for simultaneous molecular imaging, cancer cell targeting and drug delivery” (2011-2015).  Otto, PI

Alex’s Lemonade Stand Foundation for Childhood Cancer, “Development of an innovative treatment strategy for neuroblastoma and other pediatric tumors: a novel phospholipid ether analogue and its multifunctional cancer-targeting nanoconstruct” (2012-2014).  Otto, PI

Last updated: 01/04/2016
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2016 The Board of Regents of the University of Wisconsin System